Work productivity in rhinitis using cell phones: The MASK pilot study

Allergic rhinitis often impairs social life and performance. The aim of this cross‐sectional study was to use cell phone data to assess the impact on work productivity of uncontrolled rhinitis assessed by visual analogue scale (VAS). A mobile phone app (Allergy Diary, Google Play Store and Apple App...

Full description

Saved in:

Bibliographic Details
Published in:	Allergy (Copenhagen) Vol. 72; no. 10; pp. 1475 - 1484
Main Authors:	Bousquet, J., Bewick, M., Arnavielhe, S., Mathieu‐Dupas, E., Murray, R., Bedbrook, A., Caimmi, D. P., Vandenplas, O., Hellings, P. W., Bachert, C., Anto, J. M., Bergmann, K. C., Bindslev‐Jensen, C., Bosnic‐Anticevich, S., Bouchard, J., Canonica, G. W., Chavannes, N. H., Cruz, A. A., Dahl, R., Demoly, P., De Vries, G., Devillier, P., Fink‐Wagner, A., Fokkens, W. J., Fonseca, J., Guldemond, N. A., Haahtela, T., Hellqvist‐Dahl, B., Just, J., Keil, T., Klimek, L., Kowalski, M. L., Kuna, P., Kvedariene, V., Laune, D., Larenas‐Linnemann, D., Mullol, J., Pereira, A. M., Carreiro‐Martins, P., Melén, E., Morais‐Almeida, M., Nogueira‐Silva, L., O'Hehir, R. E., Papadopoulos, N. G., Passalacqua, G., Portejoie, F., Price, D., Ryan, D., Samolinski, B., Sheikh, A., Simons, F. E. R., Spranger, O., Todo Bom, A., Tomazic, P. V., Triggiani, M., Valero, A., Valovirta, E., Valiulis, A., Eerd, M., Wickman, M., Young, I., Zuberbier, T.
Format:	Journal Article
Language:	English
Published:	Denmark Blackwell Publishing Ltd 01.10.2017 Wiley
Subjects:	Allergic rhinitis Allergic Rhinitis and its Impact on Asthma Allergies Allergology app Asthma Cell Phone Efficiency Humans Hypersensitivity Immunology Life Sciences Nose Pilot Projects Productivity Public Health Surveillance rhinitis Rhinitis - diagnosis Rhinitis - epidemiology Severity of Illness Index Surveys and Questionnaires Symptom Assessment Work Performance work productivity WPAIA:AS app WPAIA:AS rhinitis Allergic Rhinitis and its Impact on Asthma work productivity
ISSN:	0105-4538, 1398-9995, 1398-9995
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Allergic rhinitis often impairs social life and performance. The aim of this cross‐sectional study was to use cell phone data to assess the impact on work productivity of uncontrolled rhinitis assessed by visual analogue scale (VAS). A mobile phone app (Allergy Diary, Google Play Store and Apple App Store) collects data from daily visual analogue scales (VAS) for overall allergic symptoms (VAS‐global measured), nasal (VAS‐nasal), ocular (VAS‐ocular) and asthma symptoms (VAS‐asthma) as well as work (VAS‐work). A combined nasal‐ocular score is calculated. The Allergy Diary is available in 21 countries. The app includes the Work Productivity and Activity Impairment Allergic Specific Questionnaire (WPAI:AS) in six EU countries. All consecutive users who completed the VAS‐work from 1 June to 31 October 2016 were included in the study. A total of 1136 users filled in 5818 days of VAS‐work. Symptoms of allergic rhinitis were controlled (VAS‐global <20) in approximately 60% of the days. In users with uncontrolled rhinitis, approximately 90% had some work impairment and over 50% had severe work impairment (VAS‐work >50). There was a significant correlation between VAS‐global calculated and VAS‐work (Rho=0.83, P<0.00001, Spearman's rank test). In 144 users, there was a significant correlation between VAS‐work and WPAI:AS (Rho=0.53, P<0.0001). This pilot study provides not only proof‐of‐concept data on the work impairment collected with the app but also data on the app itself, especially the distribution of responses for the VAS. This supports the interpretation that persons with rhinitis report both the presence and the absence of symptoms.
AbstractList	Allergic rhinitis often impairs social life and performance. The aim of this cross‐sectional study was to use cell phone data to assess the impact on work productivity of uncontrolled rhinitis assessed by visual analogue scale ( VAS ). A mobile phone app ( Allergy Diary, Google Play Store and Apple App Store) collects data from daily visual analogue scales ( VAS ) for overall allergic symptoms ( VAS ‐global measured), nasal ( VAS ‐nasal), ocular ( VAS ‐ocular) and asthma symptoms ( VAS ‐asthma) as well as work ( VAS ‐work). A combined nasal‐ocular score is calculated. The Allergy Diary is available in 21 countries. The app includes the Work Productivity and Activity Impairment Allergic Specific Questionnaire ( WPAI : AS ) in six EU countries. All consecutive users who completed the VAS ‐work from 1 June to 31 October 2016 were included in the study. A total of 1136 users filled in 5818 days of VAS ‐work. Symptoms of allergic rhinitis were controlled ( VAS ‐global <20) in approximately 60% of the days. In users with uncontrolled rhinitis, approximately 90% had some work impairment and over 50% had severe work impairment ( VAS ‐work >50). There was a significant correlation between VAS ‐global calculated and VAS ‐work (Rho=0.83, P <0.00001, Spearman's rank test). In 144 users, there was a significant correlation between VAS ‐work and WPAI : AS (Rho=0.53, P <0.0001). This pilot study provides not only proof‐of‐concept data on the work impairment collected with the app but also data on the app itself, especially the distribution of responses for the VAS . This supports the interpretation that persons with rhinitis report both the presence and the absence of symptoms. Allergic rhinitis often impairs social life and performance. The aim of this cross-sectional study was to use cell phone data to assess the impact on work productivity of uncontrolled rhinitis assessed by visual analogue scale (VAS). A mobile phone app (Allergy Diary, Google Play Store and Apple App Store) collects data from daily visual analogue scales (VAS) for overall allergic symptoms (VAS-global measured), nasal (VAS-nasal), ocular (VAS-ocular) and asthma symptoms (VAS-asthma) as well as work (VAS-work). A combined nasal-ocular score is calculated. The Allergy Diary is available in 21 countries. The app includes the Work Productivity and Activity Impairment Allergic Specific Questionnaire (WPAI:AS) in six EU countries. All consecutive users who completed the VAS-work from 1 June to 31 October 2016 were included in the study. A total of 1136 users filled in 5818 days of VAS-work. Symptoms of allergic rhinitis were controlled (VAS-global <20) in approximately 60% of the days. In users with uncontrolled rhinitis, approximately 90% had some work impairment and over 50% had severe work impairment (VAS-work >50). There was a significant correlation between VAS-global calculated and VAS-work (Rho=0.83, P<0.00001, Spearman's rank test). In 144 users, there was a significant correlation between VAS-work and WPAI:AS (Rho=0.53, P<0.0001). This pilot study provides not only proof-of-concept data on the work impairment collected with the app but also data on the app itself, especially the distribution of responses for the VAS. This supports the interpretation that persons with rhinitis report both the presence and the absence of symptoms. Allergic rhinitis often impairs social life and performance. The aim of this cross-sectional study was to use cell phone data to assess the impact on work productivity of uncontrolled rhinitis assessed by visual analogue scale (VAS). A mobile phone app (Allergy Diary, Google Play Store and Apple App Store) collects data from daily visual analogue scales (VAS) for overall allergic symptoms (VAS-global measured), nasal (VAS-nasal), ocular (VAS-ocular) and asthma symptoms (VAS-asthma) as well as work (VAS-work). A combined nasal-ocular score is calculated. The Allergy Diary is available in 21 countries. The app includes the Work Productivity and Activity Impairment Allergic Specific Questionnaire (WPAI:AS) in six EU countries. All consecutive users who completed the VAS-work from 1 June to 31 October 2016 were included in the study. A total of 1136 users filled in 5818 days of VAS-work. Symptoms of allergic rhinitis were controlled (VAS-global <20) in approximately 60% of the days. In users with uncontrolled rhinitis, approximately 90% had some work impairment and over 50% had severe work impairment (VAS-work >50). There was a significant correlation between VAS-global calculated and VAS-work (Rho=0.83, P<0.00001, Spearman's rank test). In 144 users, there was a significant correlation between VAS-work and WPAI:AS (Rho=0.53, P<0.0001). This pilot study provides not only proof-of-concept data on the work impairment collected with the app but also data on the app itself, especially the distribution of responses for the VAS. This supports the interpretation that persons with rhinitis report both the presence and the absence of symptoms.Allergic rhinitis often impairs social life and performance. The aim of this cross-sectional study was to use cell phone data to assess the impact on work productivity of uncontrolled rhinitis assessed by visual analogue scale (VAS). A mobile phone app (Allergy Diary, Google Play Store and Apple App Store) collects data from daily visual analogue scales (VAS) for overall allergic symptoms (VAS-global measured), nasal (VAS-nasal), ocular (VAS-ocular) and asthma symptoms (VAS-asthma) as well as work (VAS-work). A combined nasal-ocular score is calculated. The Allergy Diary is available in 21 countries. The app includes the Work Productivity and Activity Impairment Allergic Specific Questionnaire (WPAI:AS) in six EU countries. All consecutive users who completed the VAS-work from 1 June to 31 October 2016 were included in the study. A total of 1136 users filled in 5818 days of VAS-work. Symptoms of allergic rhinitis were controlled (VAS-global <20) in approximately 60% of the days. In users with uncontrolled rhinitis, approximately 90% had some work impairment and over 50% had severe work impairment (VAS-work >50). There was a significant correlation between VAS-global calculated and VAS-work (Rho=0.83, P<0.00001, Spearman's rank test). In 144 users, there was a significant correlation between VAS-work and WPAI:AS (Rho=0.53, P<0.0001). This pilot study provides not only proof-of-concept data on the work impairment collected with the app but also data on the app itself, especially the distribution of responses for the VAS. This supports the interpretation that persons with rhinitis report both the presence and the absence of symptoms. Allergic rhinitis often impairs social life and performance. The aim of this cross-sectional study was to use cell phone data to assess the impact on work productivity of uncontrolled rhinitis assessed by visual analogue scale (VAS). A mobile phone app (Allergy Diary, Google Play Store and Apple App Store) collects data from daily visual analogue scales (VAS) for overall allergic symptoms (VAS-global measured), nasal (VAS-nasal), ocular (VAS-ocular) and asthma symptoms (VAS-asthma) as well as work (VAS-work). A combined nasal-ocular score is calculated. The Allergy Diary is available in 21 countries. The app includes the Work Productivity and Activity Impairment Allergic Specific Questionnaire (WPAI:AS) in six EU countries. All consecutive users who completed the VAS-work from 1 June to 31 October 2016 were included in the study. A total of 1136 users filled in 5818 days of VAS-work. Symptoms of allergic rhinitis were controlled (VAS-global <20) in approximately 60% of the days. In users with uncontrolled rhinitis, approximately 90% had some work impairment and over 50% had severe work impairment (VAS-work >50). There was a significant correlation between VAS-global calculated and VAS-work (Rho=0.83, P<0.00001, Spearman's rank test). In 144 users, there was a significant correlation between VAS-work and WPAI:AS (Rho=0.53, P<0.0001). This pilot study provides not only proof-of-concept data on the work impairment collected with the app but also data on the app itself, especially the distribution of responses for the VAS. This supports the interpretation that persons with rhinitis report both the presence and the absence of symptoms.
Author	Kowalski, M. L. Bousquet, J. Canonica, G. W. Valiulis, A. Hellqvist‐Dahl, B. Valovirta, E. Bergmann, K. C. Carreiro‐Martins, P. Mathieu‐Dupas, E. Samolinski, B. Simons, F. E. R. Anto, J. M. Papadopoulos, N. G. Demoly, P. Bedbrook, A. Melén, E. Just, J. Laune, D. Spranger, O. Haahtela, T. Pereira, A. M. Todo Bom, A. Bindslev‐Jensen, C. Ryan, D. Wickman, M. Fink‐Wagner, A. Chavannes, N. H. Price, D. Arnavielhe, S. Sheikh, A. Bachert, C. Larenas‐Linnemann, D. Klimek, L. Bosnic‐Anticevich, S. Fokkens, W. J. Murray, R. Zuberbier, T. Eerd, M. Nogueira‐Silva, L. Vandenplas, O. Fonseca, J. Caimmi, D. P. Mullol, J. Triggiani, M. Kvedariene, V. Portejoie, F. Morais‐Almeida, M. Kuna, P. Bewick, M. Cruz, A. A. Valero, A. Passalacqua, G. Young, I. Keil, T. Bouchard, J. Tomazic, P. V. Hellings, P. W. O'Hehir, R. E. Guldemond, N. A. Devillier, P. Dahl, R. De Vries, G.
Author_xml	– sequence: 1 givenname: J. surname: Bousquet fullname: Bousquet, J. email: jean.bousquet@orange.fr organization: UMR‐S 1168 – sequence: 2 givenname: M. surname: Bewick fullname: Bewick, M. organization: iQ4U Consultants Ltd – sequence: 3 givenname: S. surname: Arnavielhe fullname: Arnavielhe, S. organization: Kyomed – sequence: 4 givenname: E. surname: Mathieu‐Dupas fullname: Mathieu‐Dupas, E. organization: Kyomed – sequence: 5 givenname: R. surname: Murray fullname: Murray, R. organization: MedScript Ltd – sequence: 6 givenname: A. surname: Bedbrook fullname: Bedbrook, A. organization: Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site – sequence: 7 givenname: D. P. surname: Caimmi fullname: Caimmi, D. P. organization: Montpellier University Hospital – sequence: 8 givenname: O. surname: Vandenplas fullname: Vandenplas, O. organization: Université Catholique de Louvain – sequence: 9 givenname: P. W. surname: Hellings fullname: Hellings, P. W. organization: KU Leuven – sequence: 10 givenname: C. orcidid: 0000-0003-4742-1665 surname: Bachert fullname: Bachert, C. organization: Ghent University Hospital – sequence: 11 givenname: J. M. surname: Anto fullname: Anto, J. M. organization: CIBER Epidemiología y Salud Pública (CIBERESP) & Universitat Pompeu Fabra (UPF) – sequence: 12 givenname: K. C. surname: Bergmann fullname: Bergmann, K. C. organization: Charité – Universitätsmedizin Berlin – sequence: 13 givenname: C. surname: Bindslev‐Jensen fullname: Bindslev‐Jensen, C. organization: Odense University Hospital – sequence: 14 givenname: S. surname: Bosnic‐Anticevich fullname: Bosnic‐Anticevich, S. organization: University of Sydney and Sydney Local Health District – sequence: 15 givenname: J. surname: Bouchard fullname: Bouchard, J. organization: Hôpital de La Malbaie – sequence: 16 givenname: G. W. surname: Canonica fullname: Canonica, G. W. organization: Humanitas Research Hospital – sequence: 17 givenname: N. H. surname: Chavannes fullname: Chavannes, N. H. organization: Leiden University Medical Center – sequence: 18 givenname: A. A. surname: Cruz fullname: Cruz, A. A. organization: GARD Executive Committee – sequence: 19 givenname: R. surname: Dahl fullname: Dahl, R. organization: GARD Executive Committee – sequence: 20 givenname: P. surname: Demoly fullname: Demoly, P. organization: Montpellier University Hospital – sequence: 21 givenname: G. surname: De Vries fullname: De Vries, G. organization: Peercode DV – sequence: 22 givenname: P. surname: Devillier fullname: Devillier, P. organization: Suresnes – sequence: 23 givenname: A. surname: Fink‐Wagner fullname: Fink‐Wagner, A. organization: Global Allergy and Asthma Platform GAAPP – sequence: 24 givenname: W. J. surname: Fokkens fullname: Fokkens, W. J. organization: Academic Medical Centre – sequence: 25 givenname: J. surname: Fonseca fullname: Fonseca, J. organization: CUF Porto Instituto & Hospital – sequence: 26 givenname: N. A. surname: Guldemond fullname: Guldemond, N. A. organization: Erasmus University – sequence: 27 givenname: T. surname: Haahtela fullname: Haahtela, T. organization: Helsinki University Hospital – sequence: 28 givenname: B. surname: Hellqvist‐Dahl fullname: Hellqvist‐Dahl, B. organization: Odense University Hospital – sequence: 29 givenname: J. surname: Just fullname: Just, J. organization: Equipe EPAR – sequence: 30 givenname: T. surname: Keil fullname: Keil, T. organization: University of Wuerzburg – sequence: 31 givenname: L. surname: Klimek fullname: Klimek, L. organization: Center for Rhinology and Allergology – sequence: 32 givenname: M. L. surname: Kowalski fullname: Kowalski, M. L. organization: HARC – sequence: 33 givenname: P. surname: Kuna fullname: Kuna, P. organization: Medical University of Lodz – sequence: 34 givenname: V. surname: Kvedariene fullname: Kvedariene, V. organization: Vilnius University – sequence: 35 givenname: D. surname: Laune fullname: Laune, D. organization: Kyomed – sequence: 36 givenname: D. surname: Larenas‐Linnemann fullname: Larenas‐Linnemann, D. organization: Hospital Médica Sur – sequence: 37 givenname: J. surname: Mullol fullname: Mullol, J. organization: Universitat de Barcelona – sequence: 38 givenname: A. M. surname: Pereira fullname: Pereira, A. M. organization: CUF‐Porto Hospital & Institute – sequence: 39 givenname: P. surname: Carreiro‐Martins fullname: Carreiro‐Martins, P. organization: EPE – sequence: 40 givenname: E. surname: Melén fullname: Melén, E. organization: Karolinska Institutet – sequence: 41 givenname: M. surname: Morais‐Almeida fullname: Morais‐Almeida, M. organization: Hospital CUF‐Descobertas – sequence: 42 givenname: L. surname: Nogueira‐Silva fullname: Nogueira‐Silva, L. organization: Centro Hospitalar Sao Joao – sequence: 43 givenname: R. E. surname: O'Hehir fullname: O'Hehir, R. E. organization: Monash University – sequence: 44 givenname: N. G. surname: Papadopoulos fullname: Papadopoulos, N. G. organization: University of Athens – sequence: 45 givenname: G. surname: Passalacqua fullname: Passalacqua, G. organization: IRCCS San Martino‐IST‐University – sequence: 46 givenname: F. surname: Portejoie fullname: Portejoie, F. organization: Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site – sequence: 47 givenname: D. surname: Price fullname: Price, D. organization: University of Aberdeen – sequence: 48 givenname: D. surname: Ryan fullname: Ryan, D. organization: University of Edinburgh – sequence: 49 givenname: B. surname: Samolinski fullname: Samolinski, B. organization: Medical University of Warsaw – sequence: 50 givenname: A. surname: Sheikh fullname: Sheikh, A. organization: The University of Edinburgh – sequence: 51 givenname: F. E. R. surname: Simons fullname: Simons, F. E. R. organization: University of Manitoba – sequence: 52 givenname: O. surname: Spranger fullname: Spranger, O. organization: Global Allergy and Asthma Platform GAAPP – sequence: 53 givenname: A. surname: Todo Bom fullname: Todo Bom, A. organization: University of Coimbra – sequence: 54 givenname: P. V. surname: Tomazic fullname: Tomazic, P. V. organization: Medical University of Graz – sequence: 55 givenname: M. surname: Triggiani fullname: Triggiani, M. organization: University of Salerno – sequence: 56 givenname: A. surname: Valero fullname: Valero, A. organization: Universitat Barcelona – sequence: 57 givenname: E. surname: Valovirta fullname: Valovirta, E. organization: Allergy Clinic – sequence: 58 givenname: A. surname: Valiulis fullname: Valiulis, A. organization: European Academy of Paediatrics (EAP/UEMS‐SP) – sequence: 59 givenname: M. surname: Eerd fullname: Eerd, M. organization: Peercode DV – sequence: 60 givenname: M. surname: Wickman fullname: Wickman, M. organization: Karolinska Institutet – sequence: 61 givenname: I. surname: Young fullname: Young, I. organization: Queen's University Belfast – sequence: 62 givenname: T. surname: Zuberbier fullname: Zuberbier, T. organization: Charité – Universitätsmedizin Berlin
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/28387952$$D View this record in MEDLINE/PubMed https://hal.science/hal-01763854$$DView record in HAL http://kipublications.ki.se/Default.aspx?queryparsed=id:136744526$$DView record from Swedish Publication Index (Karolinska Institutet)
BookMark	eNp1kV1PFDEUhhuDkQW98A-YJt7oxUA_p613G4JAGOKFGC-bTrfrFmanQ9uB7L-3yywYDTZpenLynHP6nvcA7PWhdwC8x-gIl3Nsuu4IUyzEKzDDVMlKKcX3wAxhxCvGqdwHByndIIQEUegN2CeSSqE4mYHTnyHewiGGxWizv_d5A30P48r3PvsEx-T7X9C6roPDqgxNX-D1ysGr-fdLOPguZJjyuNi8Ba-Xpkvu3e49BD--nl6fnFfNt7OLk3lTWU5qUQliEXJLJExbrqtJq6zF0tJWUCotrglbKEsVxi2jqpXl-8RxTCSjzGAj6CGopr7pwQ1jq4fo1yZudDBe71K3JXKaKSEoK_zniV-Z7i_4fN7obQ5hUVPJ2T0u7KeJLcu4G13Keu3TVrnpXRiTxlJyxXhNt-jHf9CbMMa-KNdY0bJbRbks1IcdNbZrt3ie_7T8AhxPgI0hpeiW2vpssg99jsZ3GiO9tVcXe_WjvX_0PFc8NX2J3XV_8J3b_B_U86aZKn4DNw2wdg
CitedBy_id	crossref_primary_10_1111_all_15371 crossref_primary_10_1002_alr_23090 crossref_primary_10_1016_j_maturitas_2019_07_023 crossref_primary_10_1186_s13601_019_0243_1 crossref_primary_10_1111_all_13431 crossref_primary_10_1159_000505745 crossref_primary_10_1111_all_15574 crossref_primary_10_1016_j_jaip_2024_02_011 crossref_primary_10_1111_all_13359 crossref_primary_10_1111_all_14204 crossref_primary_10_1186_s13601_018_0221_z crossref_primary_10_1002_clt2_12353 crossref_primary_10_1002_clt2_12390 crossref_primary_10_2196_17691 crossref_primary_10_1111_cea_13333 crossref_primary_10_2147_JAA_S501775 crossref_primary_10_1016_j_alit_2024_12_007 crossref_primary_10_1016_j_jaip_2019_12_033 crossref_primary_10_1016_j_jaip_2019_07_044 crossref_primary_10_1002_clt2_12215 crossref_primary_10_1007_s11882_018_0822_6 crossref_primary_10_1016_j_jaci_2020_02_037 crossref_primary_10_1111_all_15740 crossref_primary_10_1186_s13601_018_0210_2 crossref_primary_10_3390_pharmacy8020085 crossref_primary_10_1111_all_16234 crossref_primary_10_1016_j_jaip_2024_04_019 crossref_primary_10_1111_all_13406 crossref_primary_10_1111_all_13448 crossref_primary_10_1002_clt2_12062 crossref_primary_10_1111_cea_14135 crossref_primary_10_1016_j_jaci_2020_07_007 crossref_primary_10_1016_j_jaip_2024_03_024 crossref_primary_10_1002_clt2_12208 crossref_primary_10_1111_all_15199 crossref_primary_10_1111_all_15275 crossref_primary_10_1016_j_jaip_2024_03_039 crossref_primary_10_4168_aair_2018_10_4_370 crossref_primary_10_1111_all_14422 crossref_primary_10_1002_clt2_12128 crossref_primary_10_1111_all_14067 crossref_primary_10_1186_s13601_017_0173_8 crossref_primary_10_1016_j_jaip_2022_08_015 crossref_primary_10_1186_s13601_020_00321_2 crossref_primary_10_3390_ijgi10020046 crossref_primary_10_1186_s40413_018_0194_3 crossref_primary_10_1111_all_13218 crossref_primary_10_3389_falgy_2025_1540499 crossref_primary_10_1080_1744666X_2018_1438270 crossref_primary_10_1111_all_13617 crossref_primary_10_1016_j_rmr_2019_08_003 crossref_primary_10_1111_cea_13230 crossref_primary_10_1177_0003489418798385 crossref_primary_10_1186_s13601_018_0227_6 crossref_primary_10_1016_j_reval_2018_02_221 crossref_primary_10_1186_s13601_019_0252_0 crossref_primary_10_1016_j_jaip_2022_07_020 crossref_primary_10_1002_lary_30318 crossref_primary_10_1111_all_15880 crossref_primary_10_1111_all_16135 crossref_primary_10_1080_02770903_2019_1640728 crossref_primary_10_1111_all_13307 crossref_primary_10_1186_s13601_018_0238_3 crossref_primary_10_4168_aair_2020_12_2_238 crossref_primary_10_1111_all_13429 crossref_primary_10_1016_j_jaip_2019_11_022 crossref_primary_10_1111_all_13701 crossref_primary_10_1016_j_jaci_2019_01_053 crossref_primary_10_1016_j_jaci_2018_08_049
Cites_doi	10.1159/000210383 10.1097/ACI.0b013e3282f63d92 10.1183/09031936.00014614 10.1002/alr.21468 10.2500/ajra.2010.24.3513 10.1111/all.12528 10.1016/j.eurger.2014.09.010 10.1111/j.1398-9995.2007.01620.x 10.1111/j.1398-9995.2009.02269.x 10.1016/j.jaci.2005.09.047 10.1007/s40629-016-0006-7 10.1159/000316351 10.1159/000356317 10.3111/13696998.2011.576039 10.1016/j.jaci.2010.07.019 10.1097/MLR.0b013e318184759e 10.1016/j.anai.2009.12.003 10.1111/j.1365-2222.2011.03734.x 10.1185/03007991003750381 10.1111/cea.12701 10.1016/j.anai.2010.04.020 10.1016/j.anai.2009.11.063 10.1111/j.1398-9995.2005.00820.x 10.1016/S0140-6736(86)91008-1 10.1159/000332924 10.2500/ajra.2012.26.3799 10.1185/030079906X112552 10.2500/aap.2007.28.3062 10.1016/j.jaci.2016.03.025 10.1186/s13601-015-0083-6 10.1111/all.12686 10.1111/all.13125 10.1016/j.rmed.2009.11.005 10.1007/s00484-013-0776-2 10.1111/all.12470 10.1016/S0895-4356(00)00349-8 10.1089/tmj.2012.0020
ContentType	Journal Article
Copyright	2017 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. Copyright © 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml	– notice: 2017 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. – notice: Copyright © 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd – notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8 1XC ADTPV AOWAS
DOI	10.1111/all.13177
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic Hyper Article en Ligne (HAL) SwePub SwePub Articles
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts MEDLINE - Academic
DatabaseTitleList	CrossRef MEDLINE - Academic AIDS and Cancer Research Abstracts MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1398-9995
EndPage	1484
ExternalDocumentID	oai_swepub_ki_se_497734 oai:HAL:hal-01763854v1 28387952 10_1111_all_13177 ALL13177
Genre	article Journal Article
GrantInformation_xml	– fundername: Medical Research Council grantid: G1000758
GroupedDBID	.3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 23M 2WC 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8F7 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAKAS AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFNX AFFPM AFGKR AFRAH AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHEFC AHMBA AIACR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOETA ATUGU AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EJD EMOBN EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D P6G PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TR2 UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WVDHM WXI WXSBR XG1 Y6R ZGI ZXP ZZTAW ~IA ~KM ~WT AAYXX AIQQE CITATION O8X CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8 1XC ADTPV AOWAS
ID	FETCH-LOGICAL-c5267-72c00ef07ab07ae62b9cc18c3b7338c1624d9c3911b439b81052e5128434a1a73
IEDL.DBID	WIN
ISICitedReferencesCount	79
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000412545200004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0105-4538 1398-9995
IngestDate	Tue Nov 25 03:27:33 EST 2025 Sat Nov 29 15:01:10 EST 2025 Wed Oct 01 14:39:06 EDT 2025 Fri Oct 03 10:42:02 EDT 2025 Mon Jul 21 06:02:42 EDT 2025 Sat Nov 29 06:24:50 EST 2025 Tue Nov 18 21:36:13 EST 2025 Wed Aug 20 07:26:46 EDT 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	10
Keywords	app WPAIA:AS rhinitis Allergic Rhinitis and its Impact on Asthma work productivity
Language	English
License	http://onlinelibrary.wiley.com/termsAndConditions#vor 2017 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c5267-72c00ef07ab07ae62b9cc18c3b7338c1624d9c3911b439b81052e5128434a1a73
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ORCID	0000-0003-4742-1665 0000-0003-2401-0070 0000-0001-7827-7964 0000-0002-5646-2429 0000-0003-4481-6194 0000-0002-8607-9199
OpenAccessLink	https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/all.13177
PMID	28387952
PQID	1938389358
PQPubID	34098
PageCount	10
ParticipantIDs	swepub_primary_oai_swepub_ki_se_497734 hal_primary_oai_HAL_hal_01763854v1 proquest_miscellaneous_1885945631 proquest_journals_1938389358 pubmed_primary_28387952 crossref_citationtrail_10_1111_all_13177 crossref_primary_10_1111_all_13177 wiley_primary_10_1111_all_13177_ALL13177
PublicationCentury	2000
PublicationDate	October 2017
PublicationDateYYYYMMDD	2017-10-01
PublicationDate_xml	– month: 10 year: 2017 text: October 2017
PublicationDecade	2010
PublicationPlace	Denmark
PublicationPlace_xml	– name: Denmark – name: Zurich
PublicationTitle	Allergy (Copenhagen)
PublicationTitleAlternate	Allergy
PublicationYear	2017
Publisher	Blackwell Publishing Ltd Wiley
Publisher_xml	– name: Blackwell Publishing Ltd – name: Wiley
References	2009; 47 2015; 5 2017; 26 2015; 70 2010; 105 2015; 51 2010; 104 2010; 126 1996 2014; 69 2008; 8 2009; 150 2014; 2014 2015; 106 2005; 60 2011; 14 2006; 117 2014; 44 2007; 28 2013; 19 2017; 72 2010; 65 1986; 1 2014; 5 2010; 26 2010; 24 2006; 22 2011; 41 2014; 58 2005; 54 2010; 153 2016; 138 2008; 63 2012; 26 2012; 158 2014; 163 2016; 46 2001; 54 e_1_2_8_29_1 e_1_2_8_24_1 Kakutani C (e_1_2_8_7_1) 2005; 54 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_27_1 Konig V (e_1_2_8_28_1) 2014; 2014 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_6_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_43_1 e_1_2_8_21_1 e_1_2_8_42_1 e_1_2_8_22_1 Marcellusi A (e_1_2_8_9_1) 2015; 106 e_1_2_8_23_1 e_1_2_8_41_1 e_1_2_8_40_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_39_1 e_1_2_8_19_1 Bourret R (e_1_2_8_33_1) 2015; 51 Evans J (e_1_2_8_38_1) 1996 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_37_1 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_12_1 e_1_2_8_30_1
References_xml	– volume: 14 start-page: 305 year: 2011 end-page: 314 article-title: Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients–an observational, cross sectional study in four countries in Europe publication-title: J Med Econ – volume: 153 start-page: 395 year: 2010 end-page: 402 article-title: Efficacy of desloratadine in persistent allergic rhinitis – a GA2LEN study publication-title: Int Arch Allergy Immunol – volume: 2014 start-page: 381983 year: 2014 article-title: A model for the determination of pollen count using google search queries for patients suffering from allergic rhinitis publication-title: J Allergy (Cairo) – volume: 72 start-page: 857 year: 2017 end-page: 865 article-title: Pilot study of mobile phone technology in allergic rhinitis in European countries. The MASK‐rhinitis study publication-title: Allergy – volume: 158 start-page: 216 year: 2012 end-page: 231 article-title: Severe chronic allergic (and related) diseases: a uniform approach–a MeDALL–GA LEN–ARIA position paper publication-title: Int Arch Allergy Immunol – volume: 117 start-page: 158 year: 2006 end-page: 162 article-title: Severity and impairment of allergic rhinitis in patients consulting in primary care publication-title: J Allergy Clin Immunol – volume: 46 start-page: 668 year: 2016 end-page: 677 article-title: Is there a role for telemedicine in adult allergy services? publication-title: Clin Exp Allergy – volume: 5 start-page: 39 year: 2015 article-title: The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey publication-title: Clin Transl Allergy – volume: 5 start-page: 361 year: 2014 end-page: 362 article-title: The European innovation partnership on active and healthy ageing: the European geriatric medicine introduces the EIP on AHA column publication-title: Eur Geriatr Med – year: 1996 – volume: 26 start-page: 1389 year: 2010 end-page: 1397 article-title: The cost‐effectiveness of treatment with desloratadine in patients with persistent allergic rhinitis publication-title: Curr Med Res Opin – volume: 65 start-page: 776 year: 2010 end-page: 783 article-title: Allergic rhinitis and the common cold–high cost to society publication-title: Allergy – volume: 163 start-page: 51 year: 2014 end-page: 58 article-title: A randomized controlled trial to assess adherence to allergic rhinitis treatment following a daily short message service (SMS) via the mobile phone publication-title: Int Arch Allergy Immunol – volume: 138 start-page: 367 year: 2016 end-page: 374 article-title: MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis publication-title: J Allergy Clin Immunol – volume: 54 start-page: 610 year: 2001 end-page: 618 article-title: The work impact of asthma and rhinitis: findings from a population‐based survey publication-title: J Clin Epidemiol – volume: 22 start-page: 1203 year: 2006 end-page: 1210 article-title: Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective publication-title: Curr Med Res Opin – volume: 47 start-page: 255 year: 2009 end-page: 261 article-title: Comparison of population health status in six European countries: results of a representative survey using the EQ‐5D questionnaire publication-title: Med Care – volume: 63 start-page: 8 issue: Suppl 86 year: 2008 end-page: 160 article-title: Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen) publication-title: Allergy – volume: 8 start-page: 145 year: 2008 end-page: 149 article-title: Rhinitis and its impact on work publication-title: Curr Opin Allergy Clin Immunol – volume: 51 start-page: 36 year: 2015 end-page: 39 article-title: MASK rhinitis, a single tool for integrated care pathways in allergic rhinitis publication-title: World Hosp Health Serv – volume: 126 start-page: 926 year: 2010 end-page: 938 article-title: Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma publication-title: J Allergy Clin Immunol – volume: 69 start-page: 1275 year: 2014 end-page: 1279 article-title: Economic burden of inadequate management of allergic diseases in the European Union: a GA( ) LEN review publication-title: Allergy – volume: 24 start-page: e110 year: 2010 end-page: e113 article-title: Economic burden of allergic rhinitis in Korea publication-title: Am J Rhinol Allergy – volume: 104 start-page: 497 year: 2010 end-page: 503 article-title: Rhinitis in subjects with work‐exacerbated asthma publication-title: Respir Med – volume: 26 start-page: 16 year: 2017 end-page: 24 article-title: Visual analogue scales (VAS): measuring instruments for the documentation of symptoms and therapy monitoring in allergic rhinitis in everyday health care. Position Paper of the German Society of Allergology publication-title: Allergo J Int – volume: 1 start-page: 908 year: 1986 end-page: 909 article-title: Regression analysis publication-title: Lancet – volume: 70 start-page: 1372 year: 2015 end-page: 1392 article-title: MACVIA‐ARIA sentinel network for allergic rhinitis (MASK‐rhinitis): the new generation guideline implementation publication-title: Allergy – volume: 70 start-page: 124 year: 2015 end-page: 128 article-title: Google unveils a glimpse of allergic rhinitis in the real world publication-title: Allergy – volume: 5 start-page: 487 year: 2015 end-page: 497 article-title: The “physician on call patient engagement trial” (POPET): measuring the impact of a mobile patient engagement application on health outcomes and quality of life in allergic rhinitis and asthma patients publication-title: Int Forum Allergy Rhinol – volume: 150 start-page: 75 year: 2009 end-page: 82 article-title: Implementation of guidelines for allergic rhinitis in specialist practices. A randomized pragmatic controlled trial publication-title: Int Arch Allergy Immunol – volume: 26 start-page: 390 year: 2012 end-page: 394 article-title: Allergic rhinitis and its impact on work productivity in primary care practice and a comparison with other common diseases: the cross‐sectional study to evaluate work productivity in allergic rhinitis compared with other common diseases (CAPRI) study publication-title: Am J Rhinol Allergy – volume: 104 start-page: 118 year: 2010 end-page: 124 article-title: Psychometric validation of the rhinitis control assessment test: a brief patient‐completed instrument for evaluating rhinitis symptom control publication-title: Ann Allergy Asthma Immunol – volume: 41 start-page: 860 year: 2011 end-page: 868 article-title: Validation of a self‐questionnaire for assessing the control of allergic rhinitis publication-title: Clin Exp Allergy – volume: 19 start-page: 13 year: 2013 end-page: 18 article-title: Challenges of a mobile application for asthma and allergic rhinitis patient enablement‐interface and synchronization publication-title: Telemed J E Health – volume: 58 start-page: 1721 year: 2014 end-page: 1726 article-title: Development of personal pollen information‐the next generation of pollen information and a step forward for hay fever sufferers publication-title: Int J Biometeorol – volume: 106 start-page: 517 year: 2015 end-page: 527 article-title: Direct and indirect costs associated with respiratory allergic diseases in Italy. A probabilistic cost of illness study publication-title: Recenti Prog Med – volume: 44 start-page: 304 year: 2014 end-page: 323 article-title: Integrated care pathways for airway diseases (AIRWAYS‐ICPs) publication-title: Eur Respir J – volume: 60 start-page: 788 year: 2005 end-page: 794 article-title: Costs associated with persistent allergic rhinitis are reduced by levocetirizine publication-title: Allergy – volume: 28 start-page: 716 year: 2007 end-page: 723 article-title: Comprehensive report of the efficacy, safety, quality of life, and work impact of Olopatadine 0.6% and Olopatadine 0.4% treatment in patients with seasonal allergic rhinitis publication-title: Allergy Asthma Proc – volume: 104 start-page: 259 year: 2010 end-page: 267 article-title: Efficacy and safety of levocetirizine in improving symptoms and health‐related quality of life in US adults with seasonal allergic rhinitis: a randomized, placebo‐controlled study publication-title: Ann Allergy Asthma Immunol – volume: 105 start-page: 65 year: 2010 end-page: 74 article-title: Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis‐disturbed sleep publication-title: Ann Allergy Asthma Immunol – volume: 54 start-page: 627 year: 2005 end-page: 635 article-title: Impact of allergic rhinitis on work productivity: a pilot study publication-title: Arerugi – ident: e_1_2_8_15_1 doi: 10.1159/000210383 – ident: e_1_2_8_4_1 doi: 10.1097/ACI.0b013e3282f63d92 – ident: e_1_2_8_35_1 doi: 10.1183/09031936.00014614 – ident: e_1_2_8_30_1 doi: 10.1002/alr.21468 – ident: e_1_2_8_8_1 doi: 10.2500/ajra.2010.24.3513 – ident: e_1_2_8_27_1 doi: 10.1111/all.12528 – ident: e_1_2_8_34_1 doi: 10.1016/j.eurger.2014.09.010 – ident: e_1_2_8_2_1 doi: 10.1111/j.1398-9995.2007.01620.x – ident: e_1_2_8_6_1 doi: 10.1111/j.1398-9995.2009.02269.x – ident: e_1_2_8_10_1 doi: 10.1016/j.jaci.2005.09.047 – ident: e_1_2_8_24_1 doi: 10.1007/s40629-016-0006-7 – ident: e_1_2_8_19_1 doi: 10.1159/000316351 – ident: e_1_2_8_26_1 doi: 10.1159/000356317 – ident: e_1_2_8_11_1 doi: 10.3111/13696998.2011.576039 – ident: e_1_2_8_39_1 doi: 10.1016/j.jaci.2010.07.019 – ident: e_1_2_8_43_1 doi: 10.1097/MLR.0b013e318184759e – ident: e_1_2_8_16_1 doi: 10.1016/j.anai.2009.12.003 – ident: e_1_2_8_22_1 doi: 10.1111/j.1365-2222.2011.03734.x – ident: e_1_2_8_20_1 doi: 10.1185/03007991003750381 – ident: e_1_2_8_31_1 doi: 10.1111/cea.12701 – ident: e_1_2_8_18_1 doi: 10.1016/j.anai.2010.04.020 – volume-title: Straightforward Statistics for the Behavioral Sciences year: 1996 ident: e_1_2_8_38_1 – ident: e_1_2_8_21_1 doi: 10.1016/j.anai.2009.11.063 – ident: e_1_2_8_14_1 doi: 10.1111/j.1398-9995.2005.00820.x – ident: e_1_2_8_37_1 doi: 10.1016/S0140-6736(86)91008-1 – ident: e_1_2_8_40_1 doi: 10.1159/000332924 – ident: e_1_2_8_13_1 doi: 10.2500/ajra.2012.26.3799 – ident: e_1_2_8_12_1 doi: 10.1185/030079906X112552 – ident: e_1_2_8_17_1 doi: 10.2500/aap.2007.28.3062 – ident: e_1_2_8_23_1 doi: 10.1016/j.jaci.2016.03.025 – volume: 51 start-page: 36 year: 2015 ident: e_1_2_8_33_1 article-title: MASK rhinitis, a single tool for integrated care pathways in allergic rhinitis publication-title: World Hosp Health Serv – ident: e_1_2_8_41_1 doi: 10.1186/s13601-015-0083-6 – ident: e_1_2_8_32_1 doi: 10.1111/all.12686 – volume: 54 start-page: 627 year: 2005 ident: e_1_2_8_7_1 article-title: Impact of allergic rhinitis on work productivity: a pilot study publication-title: Arerugi – volume: 106 start-page: 517 year: 2015 ident: e_1_2_8_9_1 article-title: Direct and indirect costs associated with respiratory allergic diseases in Italy. A probabilistic cost of illness study publication-title: Recenti Prog Med – ident: e_1_2_8_36_1 doi: 10.1111/all.13125 – volume: 2014 start-page: 381983 year: 2014 ident: e_1_2_8_28_1 article-title: A model for the determination of pollen count using google search queries for patients suffering from allergic rhinitis publication-title: J Allergy (Cairo) – ident: e_1_2_8_5_1 doi: 10.1016/j.rmed.2009.11.005 – ident: e_1_2_8_29_1 doi: 10.1007/s00484-013-0776-2 – ident: e_1_2_8_42_1 doi: 10.1111/all.12470 – ident: e_1_2_8_3_1 doi: 10.1016/S0895-4356(00)00349-8 – ident: e_1_2_8_25_1 doi: 10.1089/tmj.2012.0020
SSID	ssj0007290
Score	2.5089016
Snippet	Allergic rhinitis often impairs social life and performance. The aim of this cross‐sectional study was to use cell phone data to assess the impact on work... Allergic rhinitis often impairs social life and performance. The aim of this cross-sectional study was to use cell phone data to assess the impact on work...
SourceID	swepub hal proquest pubmed crossref wiley
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	1475
SubjectTerms	Allergic rhinitis Allergic Rhinitis and its Impact on Asthma Allergies Allergology app Asthma Cell Phone Efficiency Humans Hypersensitivity Immunology Life Sciences Nose Pilot Projects Productivity Public Health Surveillance rhinitis Rhinitis - diagnosis Rhinitis - epidemiology Severity of Illness Index Surveys and Questionnaires Symptom Assessment Work Performance work productivity WPAIA:AS
Title	Work productivity in rhinitis using cell phones: The MASK pilot study
URI	https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fall.13177 https://www.ncbi.nlm.nih.gov/pubmed/28387952 https://www.proquest.com/docview/1938389358 https://www.proquest.com/docview/1885945631 https://hal.science/hal-01763854 http://kipublications.ki.se/Default.aspx?queryparsed=id:136744526
Volume	72
WOSCitedRecordID	wos000412545200004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1398-9995 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007290 issn: 0105-4538 databaseCode: WIN dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1398-9995 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007290 issn: 0105-4538 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dT9swED8BmyZexr7YwqDypmniJah2nNgeTxVQMS1U0zZG36LYcUdFVaoW-Pu5c9Jo1Zg0aQ-RLNuJ7fPd-WfnfAfwIcuUr5yoYplZHctk5ONSKkeX3RHAeq1NuF_xM1eDgR4Ozdc1OFzehan9Q7QHbiQZQV-TgJd28ZuQl5PJAcfVj26Sc8kpesHF50GrhVVzvoL4IZYo1Y1XIbLiad9cWYvWL8kS8k-Y2foQXYWvYf3pb_1Xz5_B0wZ2sl7NJ89hzU9fwJOz5sf6SzihQ3M2q92_hngSbDxl88sx2RYtGFnH_2J0yM_Ilt0vPjHkL3bW-_6FzcaT6xsW3NS-gvP-yY-j07iJsBC7VKCGVMJ1u37UVaXFx2fCGue4dolVuHV1PBOyMi5BhWgRuFiNxBQ-pSUtkSUvVbING1Ns9Q2wSlnLjfGKWyG9M7o0qUPwNHI2SyrlIthf0rpwjftxioIxKZbbECRLEcgSwfu26qz2ufFgJZywtpy8ZJ_28oLyUMmgVknlHY9gdzmfRSObiwIhqyaYluoI3rXFKFVExXLqr2-xjtapQWyZ4Cde13zQNoWAjCK0iwg-1oyx0okm6wpTvpCIrhOJQw_s8PfBFL08D4mdf6_6FjYFQYxgWLgLGzfzW78Hj90dssW8A-tqqDvw6Phb_zzvBNG4B4KKCyI
linkProvider	Wiley-Blackwell
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dT9swED8BmwYvsC8gjG3eNE28ZGocJ7YnXqoJVERaTRrbeLNix4WKqlQt8Pdz56TRKpg0aQ-RotiJnct9_Hw53wF8ynPpK8erWORWxSId-rgU0tFmdwSwXikd9lf8KuRgoM7P9fcVOFzshanzQ7QON5KMoK9JwMkh_YeUl-PxlwTNn1yFJwKBBhVu-H0yaPWwbDwsiCBigXLd5BWiOJ721iVrtHpJsZAPgWabRXQZwAYLdLz1f3N_DpsN8mTdmlVewIqfvIRn_ebf-is4Ir85m9YZYENJCTaasNnliMKL5owC5C8Y-fkZhbP7-VeGLMb63R-nbDoaX9-wkKn2Nfw8Pjr71oubIguxyzgqScldp-OHHVlaPHzOrXYuUS61ElevLsm5qLRLUSdaxC5WITW5z8iqpaJMSpluw9oER90FVklrE629TCwX3mlV6swhfho6m6eVdBEcLIhtXJOBnAphjM1iJYJkMYEsEXxsu07rtBuPdsIv1rZTouxetzB0DfUMKpZM3CUR7C8-qGnEc24QtSpCapmK4EPbjIJFVCwn_voW-yiVaYSXKT5ip2aEdijEZFSknUfwueaMpUk0l67wzBuBADsV-OqBH_7-MqZbFOFk79-7vof13lm_MMXJ4PQNbHBCHCHOcB_Wbma3_i08dXfIIrN3QTLuAYS4DLg
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9swED_adJS97PvDW7dpY4y9eMSybEmlL2Ft6KgbyraOvglLVtawkIak7d-_O1kxDd1gsAeDkGRLOt2dfpJPdwDvy1L6xvEmFaVVqcjHPq2FdHTZHQGsV0qH-xU_KjkaqbMzfbIBe6u7MK1_iO7AjSQj6GsScD9vxjekvJ5OP2W4_MlN2BIURKYHW_tfh6dVp4llPGNBDJEKlOzoWYgsebqX19ajzXOyhrwNNTs_ousQNqxBw_v_1_sHcC9iTzZomeUhbPjZI9g-jn_XH8MBnZyzeesDNgSVYJMZW5xPyMBoychE_iejk35GBu1-ucuQydjx4NsRm0-mF5cs-Kp9AqfDg--fD9MYZiF1BUc1Kbnr9_24L2uLjy-51c5lyuVW4v7VZSUXjXY5akWL6MUqpCb3Ba1ruaizWuZPoTfDVp8Da6S1mdZeZpYL77SqdeEQQY2dLfNGugQ-rohtXPRBTqEwpma1F0GymECWBN51Veet440_VsIZ68rJVfbhoDKUh5oGVUshrrMEdlYTaqKALg3iVkVYrVAJvO2KUbSIivXMX1xhHaUKjQAzx088axmhawpRGYVp5wl8aDljrRMx6xemvBEIsXOBQw_88PfBmEFVhcSLf6_6BrZP9oem-jI6egl3OUGOYGi4A73LxZV_BXfcNXLI4nUUjd9DRg1h
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Work+productivity+in+rhinitis+using+cell+phones%3A+The+MASK+pilot+study&rft.jtitle=Allergy+%28Copenhagen%29&rft.au=Bousquet%2C+J.&rft.au=Bewick%2C+M.&rft.au=Arnavielhe%2C+S.&rft.au=Mathieu-Dupas%2C+E.&rft.date=2017-10-01&rft.pub=Wiley&rft.issn=0105-4538&rft.eissn=1398-9995&rft.volume=72&rft.issue=10&rft.spage=1475&rft.epage=1484&rft_id=info:doi/10.1111%2Fall.13177&rft_id=info%3Apmid%2F28387952&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=oai%3AHAL%3Ahal-01763854v1
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-4538&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-4538&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-4538&client=summon